The global botox market forecast to reach $2.9 billion by 2018

The global botox market is forecast to reach $2.9 billion by 2018 at a CAGR of 14%. The entire global market for facial aesthetics is forecast to reach $4.7 billion in 2018, of which the US is expected to contribute over $2 billion.

Botox will continue its supremacy as a bestseller in US beauty clinics due to competitive pricing and reductions in side effects. Facial aesthetics represent a popular cosmetic treatment, as they offer long-term results at competitive prices without any need for surgical procedures. The botox market in particular is predicted to maintain its lead in terms of market share during future years, due to increased patient comfort, short procedure times and immediate results.

Botox can be used to treat chronic wrinkles of the forehead, eyelids, lips and neck, and is the most effective non-surgical anti-wrinkle solution available today, working in just five to 10 minutes. The ingredients used in botox degrade within six months, which means that both the results from treatment, as well as any adverse side effects, are temporary.

This acts to lower the risks of treatment and improve the rate of income for practitioners, especially in the US, which accounts for 40%of the botox market. In the future the botox market is going to experience high levels of competition, due to decreasing price trends in the US, which will encourage further popularity.

Currently, no facial aesthetic procedure can offer permanency, and the longevity of results which correlate with higher medical risks. Long-term botox market growth may depend upon the ability to extend the longevity of results from facial injections, in order compete more strongly against cosmetic surgery.

The report, titled 'Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018'analyses the global botox market by looking at market forecasts through to 2018. The scope of the report includes an overview of the key geographies covered including the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil. Key segments covered include Botulinum Toxin (Botox) and Dermal Fillers (HA fillers and Other Dermal Fillers) along with the key players covered such as Allergan, Q-Med, Mentor, Medicis and Merz.

For more information on the Botox Market, see the latest research: Botox Market Research

Follow us on Twitter @CandMResearch